Cargando…
A Focus on Newly Diagnosed Multiple Myeloma
Multiple myeloma (MM) is an incurable plasma cell disorder that affects nearly 35,000 people annually. Over 149,000 individuals are estimated to live in the United States with MM. Research has generated a greater understanding of the pathology of this disease, now combined with mature clinical trial...
Autores principales: | Brigle, Kevin, Verina, Daniel, Faiman, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342925/ https://www.ncbi.nlm.nih.gov/pubmed/35937466 http://dx.doi.org/10.6004/jadpro.2022.13.5.10 |
Ejemplares similares
-
A Focus on Relapsed Multiple Myeloma
por: Noonan, Kimberly, et al.
Publicado: (2022) -
A Focus on Special Populations in Relapsed Multiple Myeloma
por: Steinbach, Mary, et al.
Publicado: (2022) -
A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
por: Catamero, Donna, et al.
Publicado: (2022) -
A Focus on Waldenström Macroglobulinemia and AL Amyloidosis
por: Lu, Rebecca, et al.
Publicado: (2022) -
Recurrent seizures in a young woman: when video-EEG diagnoses a cardiac cause: a case report
por: Chaumont, Corentin, et al.
Publicado: (2020)